Aptevo Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Aptevo Therapeutics shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Aptevo Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aptevo Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Aptevo Therapeutics by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $202 | 43 | 4.70 |